» Articles » PMID: 31249649

Mangiferin Attenuates Myocardial Ischemia-Reperfusion Injury Via MAPK/Nrf-2/HO-1/NF-B and

Overview
Publisher Wiley
Date 2019 Jun 29
PMID 31249649
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the cardioprotective effect of mangiferin (MAF) and . Oxidative stress and inflammatory injury were detected in coronary artery ligation in rats and also in hypoxia-reoxygenation- (H/R-) induced H9c2 cells. MAF inhibited myocardial oxidative stress and proinflammatory cytokines in rats with coronary artery occlusion. The ST segment of MAF treatment groups also resumed. Triphenyltetrazolium chloride (TTC) staining and pathological analysis showed that MAF could significantly reduce myocardial injury. In vitro data showed that MAF could improve hypoxia/reoxygenation- (H/R-) induced H9c2 cell activity. In addition, MAF could significantly reduce oxidative stress and inflammatory pathway protein expression in H/R-induced H9c2 cells. This study has clarified the protective effects of MAF on myocardial injury and also confirmed that oxidative stress and inflammation were involved in the myocardial ischemia-reperfusion injury (I/R) model.

Citing Articles

Flavonoids as therapeutics for myocardial ischemia-reperfusion injury: a comprehensive review on preclinical studies.

Verma V, Bhardwaj P, Prajapati V, Bhatia A, Purkait S, Arya D Lab Anim Res. 2024; 40(1):32.

PMID: 39237965 PMC: 11376054. DOI: 10.1186/s42826-024-00218-2.


Green Synthesis and Chemical Characterization of Silver Nanoparticles by Tribulus terrestris for the Treatment of Myocardial Infarction.

Huang Y, Rao Z, Tan W, Zhou Y, Hu S Biol Trace Elem Res. 2024; .

PMID: 39134771 DOI: 10.1007/s12011-024-04336-9.


Tranilast reduces cardiomyocyte injury induced by ischemia‑reperfusion via Nrf2/HO‑1/NF‑κB signaling.

Wang W, Shen Q Exp Ther Med. 2023; 25(4):160.

PMID: 36911371 PMC: 9996351. DOI: 10.3892/etm.2023.11859.


Phytochemicals as potential target on thioredoxin-interacting protein (TXNIP) for the treatment of cardiovascular diseases.

Zhou P, Ma Y, Zhao X, Hua F Inflammopharmacology. 2023; 31(1):207-220.

PMID: 36609715 DOI: 10.1007/s10787-022-01130-8.


CircZNF609 Aggravated Myocardial Ischemia Reperfusion Injury via Mediation of miR-214-3p/PTGS2 Axis.

Tang W, Yang F, Chen K, Yang H, Liu Y, Dou B Korean Circ J. 2022; 52(9):680-696.

PMID: 36097836 PMC: 9470495. DOI: 10.4070/kcj.2021.0252.


References
1.
Ohki S, Iizuka K, Ishikawa S, Kano M, Dobashi K, Yoshii A . A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB/c-to-C3H/He mouse model. J Heart Lung Transplant. 2001; 20(9):956-63. DOI: 10.1016/s1053-2498(01)00292-3. View

2.
Bao W, Hu E, Tao L, Boyce R, Mirabile R, Thudium D . Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc Res. 2004; 61(3):548-58. DOI: 10.1016/j.cardiores.2003.12.004. View

3.
Lin G, Craig G, Zhang L, Yuen V, Allard M, McNeill J . Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats. Cardiovasc Res. 2007; 75(1):51-8. DOI: 10.1016/j.cardiores.2007.03.009. View

4.
Gaitanaki C, Mastri M, Aggeli I, Beis I . Differential roles of p38-MAPK and JNKs in mediating early protection or apoptosis in the hyperthermic perfused amphibian heart. J Exp Biol. 2008; 211(Pt 15):2524-32. DOI: 10.1242/jeb.018960. View

5.
Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus H . FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol. 2009; 105(2):301-13. DOI: 10.1007/s00395-009-0046-y. View